This article is from the source 'guardian' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.theguardian.com/australia-news/2018/jan/09/gas-sniffing-pill-that-transmits-from-the-gut-passes-first-human-trials

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
Gas-sniffing pill that transmits from the gut passes first human trials Gas-sniffing pill that transmits from the gut passes first human trials
(7 days later)
Scientists from Australia’s RMIT University reveal promising results from human trials of swallowable capsule that transmits data to a mobile phone
Australian Associated Press
Mon 8 Jan 2018 22.52 GMT
Share on Facebook
Share on Twitter
Share via Email
View more sharing options
Share on LinkedIn
Share on Pinterest
Share on Google+
Share on WhatsApp
Share on Messenger
Close
An electronic gas-detecting pill could help in diagnosing gastrointestinal ailments, including irritable bowel syndrome.An electronic gas-detecting pill could help in diagnosing gastrointestinal ailments, including irritable bowel syndrome.
Scientists from Melbourne’s RMIT University first unveiled their swallowable capsule early in 2015 in the hope it would it would help doctors work out what foods were problematic for their patients by detecting and measuring intestinal gases produced by gut bacteria.Scientists from Melbourne’s RMIT University first unveiled their swallowable capsule early in 2015 in the hope it would it would help doctors work out what foods were problematic for their patients by detecting and measuring intestinal gases produced by gut bacteria.
Now they have released results from the first human trials of the capsule, which collects information about the gases and transmits it to a hand-held device and mobile phone for doctors to read.Now they have released results from the first human trials of the capsule, which collects information about the gases and transmits it to a hand-held device and mobile phone for doctors to read.
A group of 26 people took part in the trials last year and proved the capsule was safe for use in humans, paving the way for more extensive tests in 2019.A group of 26 people took part in the trials last year and proved the capsule was safe for use in humans, paving the way for more extensive tests in 2019.
As a bonus, the trials delivered a surprising batch of new information about the workings of the gut’s microbiome, the colony of trillions of bacteria that are believed to help keep us healthy.As a bonus, the trials delivered a surprising batch of new information about the workings of the gut’s microbiome, the colony of trillions of bacteria that are believed to help keep us healthy.
Lead researcher and co-inventor of the capsule, Prof Kourosh Kalantar Zadeh, said they discovered the stomach releases oxidising chemicals to get rid of foreign bodies, possibly as a protection mechanism.Lead researcher and co-inventor of the capsule, Prof Kourosh Kalantar Zadeh, said they discovered the stomach releases oxidising chemicals to get rid of foreign bodies, possibly as a protection mechanism.
They also discovered that people on high-fibre diets had high amounts of oxygen in their colon – information that overturned a long-held theory that the colon was oxygen free and may help scientists work out how colon cancer develops.They also discovered that people on high-fibre diets had high amounts of oxygen in their colon – information that overturned a long-held theory that the colon was oxygen free and may help scientists work out how colon cancer develops.
“For the first time we have a tool that actually gives information about the activities of the microbiome inside the gut,” Kalantar Zadeh said.“For the first time we have a tool that actually gives information about the activities of the microbiome inside the gut,” Kalantar Zadeh said.
The scientists are trying to raise up to $8m for the next round of clinical trials of the device in 300 patients with digestive issues including irritable bowel syndrome and intestinal bacterial overgrowth.The scientists are trying to raise up to $8m for the next round of clinical trials of the device in 300 patients with digestive issues including irritable bowel syndrome and intestinal bacterial overgrowth.
All going well, they hope the capsule will be on sale by 2020 for between $100 and $200.All going well, they hope the capsule will be on sale by 2020 for between $100 and $200.
The capsule’s other co-inventor, Dr Kyle Berean, said the trial results suggested the capsule was more accurate and less invasive than existing methods used to measure intestinal gases.The capsule’s other co-inventor, Dr Kyle Berean, said the trial results suggested the capsule was more accurate and less invasive than existing methods used to measure intestinal gases.
The most common methods currently used are breath and faecal tests, however some patients undergo surgery so direct samples from the gut can be examined.The most common methods currently used are breath and faecal tests, however some patients undergo surgery so direct samples from the gut can be examined.
The results from the first human trials were published on Thursday in the journal Nature Electronics.The results from the first human trials were published on Thursday in the journal Nature Electronics.
Health
Health
(Society)
Cancer research
Medical research
news
Share on Facebook
Share on Twitter
Share via Email
Share on LinkedIn
Share on Pinterest
Share on Google+
Share on WhatsApp
Share on Messenger
Reuse this content